Coral Labs Q3FY26 Net Profit Drops 55% to ₹277.55 Lakhs

Coral Laboratories reported Q3FY26 net profit of ₹277.55 lakhs, down 54.84% YoY. Revenue declined 6.19% to ₹2156.42 lakhs while nine-month profit fell 47.70% to ₹1115.74 lakhs.

Coral Laboratories Company Secretary Resigns

Coral Laboratories announces resignation of Company Secretary and Compliance Officer Mrs. Dhwani Desai, effective January 31, 2026, to pursue new career opportunities.

Coral Laboratories Reports Q2 FY26 Results with 582.01 Lakh Net Profit

Coral Laboratories Limited announced unaudited standalone financial results for the quarter and half year ended September 30, 2025, reporting a net profit of 582.01 lakh for the quarter compared to 637.98 lakh in the same quarter last year. The company's revenue from operations stood at 1903.48 lakh for the quarter, with the Board of Directors approving these results in their meeting held on November 14, 2025.

Coral Laboratories Approves Quarterly Results, Sets AGM Date and Appoints New Auditors

Coral Laboratories Limited's Board approved unaudited financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs 1,882.14 lakhs and total income of Rs 2,086.96 lakhs for the quarter, with profit for the period at Rs 256.43 lakhs. Earnings per share stood at Rs 7.18. The Board fixed September 26, 2025 as the date for the 43rd Annual General Meeting. M/s. S C Mehra & Associates LLP was appointed as statutory auditors for five years from FY 2025-26 to 2029-30, replacing M/s M. A. Parekh & Associates whose term concludes at the upcoming AGM. The Board also approved alterations to the company's Memorandum of Association object clause, expanding business activities to include manufacturing and trading of pharmaceutical, medicinal, chemical, biological products and veterinary medicines for human and animal healthcare.